GPT and Hepatic steatosis: The results showed that UC-MSC treatment alleviated hepatic functional injury, attenuated hepatic steatosis, and reduced hepatic lipid accumulation, as evidenced by markedly decreased serum levels of ALT and AST, lowered AST/ALT ratio, and alleviated histological lesion of liver tissue.